Nova Leap Health First Quarter 2024 Earnings: EPS: US$0.005 (vs US$0.003 loss in 1Q 2023)

[email protected] (Simply Wall St)
1 min read

In This Article:

Nova Leap Health (CVE:NLH) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$6.43m (flat on 1Q 2023).

  • Net income: US$473.1k (up from US$296.9k loss in 1Q 2023).

  • Profit margin: 7.4% (up from net loss in 1Q 2023).

  • EPS: US$0.005 (up from US$0.003 loss in 1Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Nova Leap Health shares are up 8.0% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Nova Leap Health you should be aware of, and 1 of them makes us a bit uncomfortable.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Recommended Stories